Philips expands commercial availability of LumiGuide imaging system

45

LumiGuide in use

Philips has announced the expanded commercial availability of LumiGuide 3D device guidance—the much-heralded first real-time artificial intelligence (AI)-enabled light-based navigation solution for image-guided therapy—across Europe and the USA. 

LumiGuide integrates with Philips’ Azurion platform, which is designed to drive procedural innovation across clinical domains.

“I have done over 160 fenestrated and branched aortic procedures with LumiGuide and have found that the system improves efficiency, reduces the procedure time, and reduces time on the fluoroscopy pedal to near zero,” said Adam W. Beck (University of Alabama at Birmingham, USA).

LumiGuide, powered by Philips Fiber Optic RealShape (FORS) technology, is the first solution to use light to visualize the shape and position of LumiGuide wires and compatible endovascular catheters inside the body in real time and in 3D without X-ray.

Following a limited market release in late 2023, LumiGuide will be commercially available from January 2026 in key European markets and the United States, Philips reported.


LEAVE A REPLY

Please enter your comment!
Please enter your name here